Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001385903 | SCV001585920 | pathogenic | not provided | 2023-04-26 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu1501*) in the ABCA4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCA4 are known to be pathogenic (PMID: 10958761, 24938718, 25312043, 26780318). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1073023). This variant has not been reported in the literature in individuals affected with ABCA4-related conditions. This variant is not present in population databases (gnomAD no frequency). |
Gene |
RCV001385903 | SCV002538705 | pathogenic | not provided | 2022-06-23 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge |
Institute for Human Genetics and Genomic Medicine, |
RCV004699132 | SCV005201048 | pathogenic | Severe early-childhood-onset retinal dystrophy | criteria provided, single submitter | clinical testing | the detected variant is reported once in gnomAD (1/1582616), and has been reported as pathogenic to ClinVar. It creates a nonsense coding effect and was classified as pathogenic (ACMG: PVS1, PS1, PM2, PM3, PP3) |